Your Complete Guide to Global Clinical Research and GCP Compliance
Training Investigators and Sites to Execute SUSAR Detection & Expedited Reporting Reliably Training Investigators and Sites to Execute SUSAR Detection & Expedited Reporting Reliably In the context of clinical trials, recognizing and reporting Serious Unexpected Serious Adverse Reactions (SUSARs) is a critical component of patient safety and regulatory compliance. This detailed guide aims to equip…
Training Sites and Study Teams to Use IRT/IWRS & Supply Management Effectively Training Sites and Study Teams to Use IRT/IWRS & Supply Management Effectively Introduction to IRT/IWRS and Their Role in Clinical Trials Interactive Response Technology (IRT) and Interactive Web Response Systems (IWRS) have become integral tools in the clinical trial landscape. These technologies streamline…
Read More “Training Sites and Study Teams to Use IRT/IWRS & Supply Management Effectively” »
Data Standards, Interoperability and Metadata Strategies for IRT/IWRS & Supply Management Data Standards, Interoperability and Metadata Strategies for IRT/IWRS & Supply Management In the evolving landscape of clinical trials, the emphasis on data standards, interoperability, and metadata management has become paramount for effective Interactive Response Technology (IRT) and Interactive Web Response Systems (IWRS). This guide…
Inspection-Ready Documentation Standards for SUSAR Detection & Expedited Reporting Inspection-Ready Documentation Standards for SUSAR Detection & Expedited Reporting In today’s complex landscape of clinical research, the accurate and timely reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) is of paramount importance. Regulatory bodies like the FDA, EMA, and MHRA require comprehensive documentation standards to ensure…
Read More “Inspection-Ready Documentation Standards for SUSAR Detection & Expedited Reporting” »
KRIs, KPIs and Dashboards to Monitor SUSAR Detection & Expedited Reporting Across Portfolios KRIs, KPIs and Dashboards to Monitor SUSAR Detection & Expedited Reporting Across Portfolios The monitoring of Serious Unexpected Suspected Adverse Reactions (SUSARs) is essential in clinical trials to ensure patient safety and regulatory compliance. In this step-by-step tutorial, we will delve into…
Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight In the realm of clinical trials, the detection and expedited reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) is paramount to ensuring participant safety and regulatory compliance. This article serves as a tutorial…
Read More “Case Studies: SUSAR Detection & Expedited Reporting That Strengthened Safety Oversight” »
Cybersecurity, Privacy and Access Control Considerations for IRT/IWRS & Supply Management In the fast-evolving landscapes of clinical trials, particularly those focusing on psoriatic arthritis clinical trials, ensuring robust cybersecurity, privacy, and access control mechanisms in Interactive Response Technology (IRT) and Interactive Web Response Systems (IWRS) is paramount. As clinical operations, regulatory affairs, and medical affairs…
Vendor Oversight and SLA Design for Mission-Critical IRT/IWRS & Supply Management In the rapidly evolving landscape of clinical trials, effective vendor oversight and the establishment of Service Level Agreements (SLAs) are essential components for ensuring the success of Interactive Response Technology (IRT) and Interactive Web Response Systems (IWRS). This article serves as a comprehensive guide…
Read More “Vendor Oversight and SLA Design for Mission-Critical IRT/IWRS & Supply Management” »
Common Pitfalls in SUSAR Detection & Expedited Reporting—and How to Avoid Regulatory Findings Common Pitfalls in SUSAR Detection & Expedited Reporting—and How to Avoid Regulatory Findings In the highly regulated environment of clinical research, the accurate detection and expedited reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) are critical components of ensuring patient safety, maintaining…
Aligning SUSAR Detection & Expedited Reporting With GCP, ICH E2A–E2F and Local Regulations Aligning SUSAR Detection & Expedited Reporting With GCP, ICH E2A–E2F and Local Regulations In the complex landscape of clinical trials, the detection and reporting of Suspected Unexpected Serious Adverse Reactions (SUSARs) are critical components that must align with regulatory frameworks such as…
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.